Insights Home Insights Featured Content Blog Juror Attitudes Toward Expert Witnesses for High Tech Patent Litigation and Building a Next-Level Expert Witness Team Engaging with experts who can provide clarity, support legal strategies, and ensure that the innovative essence of the patent is fully understood in its legal context will decisively influence the trajectory and outcome of the case. Blog Expert Perspective: Understanding How 5G Patent Expansion Creates Litigation Risk As 5G rollouts become more widespread and connectivity capabilities expand, the technology required to utilize this new generation of the spectrum is prompting an increase in patent activity in the space. Learn what wireless expert and WIT Panel Member Muriel Medard has to say about this influx in IP in the space. Blog Securities Laws Spark Conflicts in NFT Space for the Next Wave of Digital Asset Litigation As we know, Binance, Coinbase, FTX, and other major cryptocurrency industry players have long been engaged in hefty lawsuits brought on by the Securities Exchange Commission and investors; but recently, litigators have had their sights on another volatile digital asset: NFTs. Let's evaluate the NFT landscape as it stands today, and take a look at where litigation may lie as the digital assest industry evolves. Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. Blog Building Your Expert Witness Team for Pharmaceutical Litigation Identifying the areas where expert testimony can enhance your position on a case and building an effective team of highly credentialed experts can help you deliver successful litigation outcomes. Insights & News All Industries Technology Pharmaceutical Healthcare Technology Biotechnology Sexual Misconduct & Harassment Wireless Communications Gaming Financial Technology Automotive Complex Commercial Life Sciences Intellectual Property Energy & Natural Resources Employment Crisis Management All Trends 2023 Banking Crisis Lab-Grown Foods Wearable Devices Cryptocurrency FDA-Regulated Drugs and Devices Payment Systems Virtual Reality Electric Vehicles Election Law and Voting Rights 5G / 6G Drug and Vaccine Development COVID-19 All Insight Types Archive Article Blog Case Study Event In the News Other Content Press Release Video Search November 2, 2023 — Blog Building Your Expert Witness Team for Pharmaceutical Litigation Identifying the areas where expert testimony can enhance your position on a case and building an effective team of highly credentialed experts can help you deliver successful litigation outcomes. October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond. September 12, 2023 — Case Study Case Study: Clinical Psychiatric Expert Requested for Generic Drug Dispute For this case, a major drug manufacturer sued to stop generic release of schizophrenia drug. Learn how WIT was able to meet the expert need and see how an increase in ANDA cases may affect the industry. September 7, 2023 — Case Study Case Study: Regulatory Affairs, Quality, and Compliance Expert Needed for Breach of Contract Drug Manufacturing Dispute A breach of contract case between two pharmaceutical companies called for an expert with hands-on experience with biologics license applications (BLAs) and the role of manufacturing capabilities in BLA reviews. Let's look at how they assisted in the case and where future conflicts may lie. July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets. February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP. July 14, 2021 — Blog FDA Approvals, Controversial Therapeutics, and the Experts Needed for Litigation Therapeutics are some of the most complicated, most regulated, and most litigated products existing in the market today. Any inconsistencies to the qualification and validation protocols of the product can cause undue harm, lasting damage, and unlimited claims of liability. June 16, 2021 — Blog Biologics vs. Biosimilars – Driving Innovation, BPCIA Litigation, and a Need for Experts With patents for several existing biological drugs set to expire in the coming decade, biosimilar companies and manufacturers have an opportunity to take advantage. Load More Loading...
Blog Juror Attitudes Toward Expert Witnesses for High Tech Patent Litigation and Building a Next-Level Expert Witness Team Engaging with experts who can provide clarity, support legal strategies, and ensure that the innovative essence of the patent is fully understood in its legal context will decisively influence the trajectory and outcome of the case.
Blog Expert Perspective: Understanding How 5G Patent Expansion Creates Litigation Risk As 5G rollouts become more widespread and connectivity capabilities expand, the technology required to utilize this new generation of the spectrum is prompting an increase in patent activity in the space. Learn what wireless expert and WIT Panel Member Muriel Medard has to say about this influx in IP in the space.
Blog Securities Laws Spark Conflicts in NFT Space for the Next Wave of Digital Asset Litigation As we know, Binance, Coinbase, FTX, and other major cryptocurrency industry players have long been engaged in hefty lawsuits brought on by the Securities Exchange Commission and investors; but recently, litigators have had their sights on another volatile digital asset: NFTs. Let's evaluate the NFT landscape as it stands today, and take a look at where litigation may lie as the digital assest industry evolves.
Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
Blog Building Your Expert Witness Team for Pharmaceutical Litigation Identifying the areas where expert testimony can enhance your position on a case and building an effective team of highly credentialed experts can help you deliver successful litigation outcomes.
November 2, 2023 — Blog Building Your Expert Witness Team for Pharmaceutical Litigation Identifying the areas where expert testimony can enhance your position on a case and building an effective team of highly credentialed experts can help you deliver successful litigation outcomes.
October 2, 2023 — Article Expert Perspective: What is Driving Growth and Litigation in the Biotechnology Space? The biotechnology market is headed towards transformational growth as the landscape shifts, resulting from impending patent cliffs, increased M&A activity, and ongoing innovation. WIT biotech expert Peter Lankau provides insights on what's to come in the industry for the remainder of this year and beyond.
September 12, 2023 — Case Study Case Study: Clinical Psychiatric Expert Requested for Generic Drug Dispute For this case, a major drug manufacturer sued to stop generic release of schizophrenia drug. Learn how WIT was able to meet the expert need and see how an increase in ANDA cases may affect the industry.
September 7, 2023 — Case Study Case Study: Regulatory Affairs, Quality, and Compliance Expert Needed for Breach of Contract Drug Manufacturing Dispute A breach of contract case between two pharmaceutical companies called for an expert with hands-on experience with biologics license applications (BLAs) and the role of manufacturing capabilities in BLA reviews. Let's look at how they assisted in the case and where future conflicts may lie.
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets.
February 22, 2023 — Blog Pharmaceutical Industry’s Drug Patent Cliffs Approach, Giving Rise to the Need for Highly Credentialed Experts Several patents from the pharmaceutical industry’s best-selling drugs are set to expire. As a result, competition intensifies with copycat drugs already in the works and counsel strategizing on protecting monetized IP.
July 14, 2021 — Blog FDA Approvals, Controversial Therapeutics, and the Experts Needed for Litigation Therapeutics are some of the most complicated, most regulated, and most litigated products existing in the market today. Any inconsistencies to the qualification and validation protocols of the product can cause undue harm, lasting damage, and unlimited claims of liability.
June 16, 2021 — Blog Biologics vs. Biosimilars – Driving Innovation, BPCIA Litigation, and a Need for Experts With patents for several existing biological drugs set to expire in the coming decade, biosimilar companies and manufacturers have an opportunity to take advantage.
